Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Coronary Artery Disease Scores
Mapped score9 clinical inputsPatient data not stored

DAPT Score (Dual Antiplatelet Therapy) Calculator

DAPT Score: Comprehensive Explanation and Clinical Context The Dual Antiplatelet Therapy (DAPT) Score is a validated clinical tool developed to help physicians decide whether to extend dual antiplatelet therapy beyond 12 months after coronary stent implantation. It balances ischemic benefit against bleeding risk based on nine clinical and procedural variables. A score of >2 suggests that prolonged DAPT may reduce the

Interactive calculator

Clinical inputs

0/9 filled
Inputs stay on this device
Mapped calculationNumeric option weights were mapped from the audited source form; confirm score use and interpretation against current guidance.
Show formulaSum of the numeric option weights
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

DAPT Score: Comprehensive Explanation and Clinical Context The Dual Antiplatelet Therapy (DAPT) Score is a validated clinical tool developed to help physicians decide whether to extend dual antiplatelet therapy beyond 12 months after coronary stent implantation. It balances ischemic benefit against bleeding risk based on nine clinical and procedural variables. A score of >2 suggests that prolonged DAPT may reduce the risk of ischemic events (such as myocardial infarction or stent thrombosis) more than it increases bleeding risk.

Conversely, a score of <2 indicates that extending DAPT is unlikely to provide a net benefit and may increase bleeding complications. Clinical Application: The DAPT Score should be applied only in patients who have completed 12 months of DAPT without major bleeding or ischemic events. It is based on data from the DAPT Trial (Mauri et al., NEJM 2014) and subsequent validation studies.

Evidence & references4 primary sources mapped
  1. Source 1

    Yeh RW, et al. JAMA. 2016;315(16):1735–1749.

  2. Source 2

    Mauri L, et al. N Engl J Med. 2014;371(23):2155–2166.

  3. Source 3

    ESC Guidelines for the Management of Acute Coronary Syndromes (2023).

  4. Source 4

    ACC/AHA Focused Update on Duration of DAPT in CAD. Circulation. 2016.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Formula confidence

Structure mapped

Numeric option weights were mapped from the audited source form; confirm score use and interpretation against current guidance.

On this pageCalculator Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Score mapped

CADILLAC Risk Score Calculator

Coronary Artery Disease Scores
Interactive worksheet

DAPT De Escalation Strategy Calculator Ticagrelor or Prasugrel to Clopidogrel

Coronary Artery Disease Scores
Interactive worksheet

NSTE ACS Routine Versus Selective Invasive Strategy Decision Tool

Coronary Artery Disease Scores
Score mapped

PAMI Risk Score Calculator

Coronary Artery Disease Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.